| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,025 | 989 | 1,142 | 1,848 | | Cost of Revenue | 970 | 1,110 | 1,159 | 1,427 | | | Gross Profit | 55 | (121) | (17) | 421 | | | Operating Expenses | | Research Development |
-
| 1,110 |
-
|
-
| | Selling General and Administrative | 1,073 | 1,074 | 2,260 | 869 | | Non Recurring |
-
|
-
|
-
| 631 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,018) | (1,195) | (1,646) | (1,079) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,018) | (1,195) | (1,840) | (1,079) | | Interest Expense | 61 | 60 | 57 | 54 | | Income Before Tax | (1,079) | (1,255) | (1,703) | (1,133) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,079) | (1,255) | (1,703) | (1,133) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,079) | (1,255) | (1,703) | (1,133) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,079) | ($1,255) | ($1,703) | ($1,133) |
|
0.20% Nasdaq 
Income Statement
